90 related articles for article (PubMed ID: 5619112)
1. [Leucinose. II. Study of heterozygotes].
Fontaine G; Dautrevaux M; Farriaux JP; Biserte G
Lille Med; 1967 Apr; 12(4):480-3. PubMed ID: 5619112
[No Abstract] [Full Text] [Related]
2. Maple syrup urine disease (branched-chain keto-aciduria) variant type manifesting as hyperkinetic behaviour and mental retardation. Report of two cases.
Kalyanaraman K; Chamukuttan S; Arjundas G; Gajanan N; Ramamurthi B
J Neurol Sci; 1972 Feb; 15(2):209-17. PubMed ID: 5010106
[No Abstract] [Full Text] [Related]
3. Family with intermittent maple syrup urine disease.
Valman HB; Patrick AD; Seakins JW; Platt JW; Gompertz D
Arch Dis Child; 1973 Mar; 48(3):225-8. PubMed ID: 4693464
[TBL] [Abstract][Full Text] [Related]
4. Assessment of whole body L-leucine oxidation by noninvasive L-[1-13C]leucine breath tests: a reappraisal in patients with maple syrup urine disease, obligate heterozygotes, and healthy subjects.
Schadewaldt P; Bodner A; Brösicke H; Hammen HW; Wendel U
Pediatr Res; 1998 May; 43(5):592-600. PubMed ID: 9585004
[TBL] [Abstract][Full Text] [Related]
5. Intermittent branched chain ketonuria (variant of maple syrup urine disease).
Irwin WC; Martel SB; Goluboff N
Clin Biochem; 1971 Jun; 4(2):52-8. PubMed ID: 5128296
[No Abstract] [Full Text] [Related]
6. [On the clinical picture and pathological anatomy of the maple syrup disease ("branded chain ketoaciduria"). Report on 2 cases in 1 family].
Sander C; Clotten R; Noetzel H; Wehinger H
Dtsch Med Wochenschr; 1968 May; 93(18):895-903 passim. PubMed ID: 5650843
[No Abstract] [Full Text] [Related]
7. [Maple syrup urine disease].
Rokkones T
Tidsskr Nor Laegeforen; 1970 Jan; 90(2):239-42. PubMed ID: 5430195
[No Abstract] [Full Text] [Related]
8. Biochemical studies on a variant of branched chain ketoaciduria in a 19-year-old female.
Fischer MH; Gerritsen T
Pediatrics; 1971 Nov; 48(5):795-801. PubMed ID: 5125877
[No Abstract] [Full Text] [Related]
9. Multiple exchange transfusions as treatment during the acute period in maple syrup urine disease.
Schuchmann L; Witt I; Schulz P; Schumacher H; Rüdiger H
Helv Paediatr Acta; 1972 Sep; 27(4):449-56. PubMed ID: 4644280
[No Abstract] [Full Text] [Related]
10. [Maple syrup urine disease with an intermittent relatively benign course].
Müller H; Bickel H; Feist D; Lutz P
Dtsch Med Wochenschr; 1971 Oct; 96(40):1552-7. PubMed ID: 5093339
[No Abstract] [Full Text] [Related]
11. Gas-liquid chromatography of alpha-keto acids: quantification of the branched-chain-alpha-keto acids from physiological sources.
Cree TC; Hutson SM; Harper AE
Anal Biochem; 1979 Jan; 92(1):159-63. PubMed ID: 426274
[No Abstract] [Full Text] [Related]
12. [Maple syrup urine disease: report of a mild variant case and results of dietary treatment].
Stoppoloni G; Santinelli R; Prisco F; Tolone C; D'Ambrosio M
Pediatria (Napoli); 1978 Sep; 86(3):409-20. PubMed ID: 754161
[No Abstract] [Full Text] [Related]
13. Peritoneal dialysis in maple-syrup-urine disease: studies on branched-chain amino and keto acids.
Wendel U; Becker K; Przyrembel H; Bulla M; Manegold C; Mench-Hoinowski A; Langenbeck U
Eur J Pediatr; 1980 Jun; 134(1):57-63. PubMed ID: 7408911
[No Abstract] [Full Text] [Related]
14. Quantitative analysis of branched-chain alpha-keto acids as their trimethylsilylated oximes.
Lancaster G; Lamm P; Scriver CR; Tjoa SS; Mamer OA
Clin Chim Acta; 1973 Oct; 48(3):279-85. PubMed ID: 4765708
[No Abstract] [Full Text] [Related]
15. A new variant of maple syrup urine disease (branched chain ketoaciduria). Clinical and biochemical evaluation.
Schulman JD; Lustberg TJ; Kennedy JL; Museles M; Seegmiller JE
Am J Med; 1970 Jul; 49(1):118-24. PubMed ID: 5431474
[No Abstract] [Full Text] [Related]
16. Plasma amino acid analyses in two cases of maple syrup urine disease.
Surarit R; Srisomsap C; Wasant P; Svasti J; Suthatvoravut U; Chokchaichamnankit D; Liammongkolkul S
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():138-9. PubMed ID: 11400750
[TBL] [Abstract][Full Text] [Related]
17. Determination of alpha-keto acids as silylated oximes in urine and serum by combined gas chromatography-mass spectrometry.
Sternowsky HJ; Roboz J; Hutterer F; Gaull G
Clin Chim Acta; 1973 Sep; 47(3):371-9. PubMed ID: 4795614
[No Abstract] [Full Text] [Related]
18. The gas-chromatographic diagnosis of intermittent maple syrup urine disease (branch-chain ketoaciduria).
Gompertz D; Draffan GH
Clin Chim Acta; 1972 Aug; 40(1):5-11. PubMed ID: 5056643
[No Abstract] [Full Text] [Related]
19. Amino acids levels and lipid peroxidation in maple syrup urine disease patients.
Barschak AG; Sitta A; Deon M; Busanello EN; Coelho DM; Cipriani F; Dutra-Filho CS; Giugliani R; Wajner M; Vargas CR
Clin Biochem; 2009 Apr; 42(6):462-6. PubMed ID: 19121297
[TBL] [Abstract][Full Text] [Related]
20. [Biochemical studies in a patient with maple syrup urine disease (author's transl)].
Vaca G; Rivas F; Sánchez-Corona J; Olivares N; Aguirre-Negrete MG; González-Quiroga G; Medina C; Hernández A; Cantú JM
Rev Invest Clin; 1981; 33(4):379-82. PubMed ID: 7330511
[No Abstract] [Full Text] [Related]
[Next] [New Search]